(Q84857107)
Statements
Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients: a continuous glucose monitoring-based study (English)
Yukiko Taniguchi
Yutaka Mori
Kazunori Sezaki
Junichi Yokoyama
Kazunori Utsunomiya
30 August 2011